Kanuni Sultan Süleyman Training and Research Hospital
Istanbul, 33404, Turkey (Türkiye)
NCT Number: NCT04071288
Stress urinary incontinence is common in women. the treatment of this condition is surgery. investigators add stress incontinence surgery to patients who undergo total laparoscopic hysterectomy for benign reasons.
Depending on the patient's general condition and indications, the operation can be performed by vaginal approach, as well as mid-urethral sling operations and laparoscopic burch colposuspension.
The researchers aimed to compare these two types of operations performed on patients. In this way, the superiority and disadvantage of each other in two procedures will be demonstrated.
Looking for future studies?
Notify Me18 year–45 year
Female
Observational
Istanbul, 33404, Turkey (Türkiye)
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
total laparoscopic hysterectomy and simultaneous incontinence surgery with benign causes; Burch colposuspension and mid-urethral sling operations for stress urinary incontinence
Time frame: 2 years
in patients who underwent total laparoscopic hysterectomy and simultaneous incontinence surgery for benign reasons; In the early postoperative period, relapse will be evaluated at 1 month, 6 months and 12 months.
Kanuni Sultan Suleyman Training and Research Hospital
Other
Comparison of Burch Colposuspension and Mid-urethral Sling Operations for Stress Urinary Incontinence
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06206512
Cardiovascular Diseases, Female Urogenital Diseases
Dallas, Texas, United States
View Trial DetailsNCT06470620
Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications
Haifa, Haifa District, Israel
View Trial DetailsNCT04491617
Agnosia, Incontinence
Cleveland, Ohio, United States
View Trial DetailsNCT05960734
Cancer, Incontinence
Oviedo, Principality of Asturias, Spain
View Trial Details